Although executives and managers lead the way, in large part, the answer is doctors. See the chart below.
Sources:
- John Bakija, Williams College ”Jobs and Income Growth of Top Earners and the Causes of Changing Income Inequality: Evidence from U.S. Tax Return Data.” November 2010, Working Paper.
- Hat tip: Mother Jones.
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in now[...] response to these comments are likely, ‘that’s it?!?!’ If you look at the State of the Union address from 2010, you’ll notice that health care reform played a large role in the President’s State of [...]
[...] From Jason Shafrin, the Healthcare Economist: Medicare’s new value-based purchasing initiative, which aims to reduce payment to “low-quality” doctors, currently uses treatment costs for which of the following chronic diseases as an element of its cost measure (as distinct from its quality measure): a) Hypertension b) Alzheimer’s disease c) Diabetes d) Lung cancer e) Breast cancer [...]
Good information, thanks.
[...] 1. Engage individuals in their health throughout their life, during life transitions and propose recommendations centered on micro-segments. This approach would automatically group individuals of like-inclinations and make health products and services recommendations that extend beyond simply dealing with health care services based on episodes of illness. [...]
[...] I’ve been busy lately, and haven’t been participating in the Health Wonk Review. Fortunately, others have kept it going without me–imagine that! This time around, in honor of the start of baseball season, Jason Shafrin–the Healthcare Economist–presents the “Opening Day” edition of HWR. It is overflowing with wonky goodness. Check it out here. [...]
[...] turns to how to finance these approaches. One oft-mentioned mechanism is pay for performance. Jason Shafrin of the Healthcare Economist takes a look at an interesting study that examines whether the [...]
[...] Shafrin of the Health Economist blog hosts the latest Health Wonk Review. Lots of good stuff in there this time (including a post of mine)–and his tenuous connection [...]
[...] it takes an estimated $800 million over a 7.5 year time span to produce a new drug these days, I don’t have much of a problem handing over a few bucks if [...]
Acupuncture…
Acupuncture is the insertion of very fine needles into specific acupuncture points along the meridians or channels connected to different organs in Chinese medicine. The western medical research has shown that acupuncture can produce various chemicals …
While ACOs aren’t perfect. The idea is a step in the right direction.
I agree that the burden from cost of malpractice, especially from
Need for defensive medicine will urgently needs to be addressed.
A mechanism also needs to be in place to fine tune the process as
we moved forward.
To read more about the medical loss ratio and its affect on small businesses check out the American Action Forum http://bit.ly/vyqxhj
[...] Jason Shafrin is a Ph.D. Economist and Research Associate at Acumen, LLC. His research interests include all issues related to healthcare policy and economics, the health insurance market, and Medicare research. Shafrin is also founder of the blog Healthcare Economist, where this post was originally found. [...]
To read about Medicaid reform and its financial struggles in various states, check out the American Action Forum http://bit.ly/xwWVpB
I believe the correct code for Kansas is KS.
going solo roald dahl pdf…
[...]Healthcare Economist · A Tale of Two Bounties: Can Physicians Cost Shift from Medicare to Private-Pay Patients[...]…
Colorectal Cancer – Prevention Tips and Treatment Methods…
Cancer of the colon and rectum is the third biggest author of Cancer in males and the fourth biggest author of Cancer in females. The prevalence of colorectal Cancer varies around the world. Colorectal cancer, also called colon cancer. In the United St…
[...] my opinion the answer is yes. A book by Coulam, Feldman and Dowd also would agree with [...]